Advances in surgery for movement disorders

Movement Disorders

Volumn 32, Issue 1, 2017, Pages 5-10

  Rowland, Nathan C ^a   Sammartino, Francesco ^a   Lozano, Andres M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Parkinson's disease; deep brain stimulation; dystonia; essential Tremor; technology

Indexed keywords

ARTIFICIAL INTELLIGENCE; BRAIN DEPTH STIMULATION; GENE THERAPY; HUMAN; MEDICAL TECHNOLOGY; MINIMALLY INVASIVE SURGERY; MOTOR DYSFUNCTION; NANOTECHNOLOGY; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREND STUDY; LEGISLATION AND JURISPRUDENCE; NEUROSURGERY; PROCEDURES; TRENDS;

HUMANS; MOVEMENT DISORDERS; NEUROSURGICAL PROCEDURES;

EID: 85010468251     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26636     Document Type: Review

References (67)

1. Brice J, McLellan L. Suppression of intention tremor by contingent deep-brain stimulation. Lancet 1980;1:1221-1222.
2. Lozano AM, Lipsman N. Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron 2013;77:406-424.
3. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
4. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-591.
5. Schüpbach WMM, Maltête D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 2007;68:267-271.
6. Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610-622.
7. Charles PD, Dolhun RM, Gill CE, et al. Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial. Parkinsonism Relat Disord 2012;18:268-273.
8. Charles D, Konrad PE, Neimat JS, et al. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord 2014;20:731-737.
9. Starr PA, Rau GM, Davis V, M et al. Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J Neurophysiol 2005;93:3165-3176.
10. Chang EF, Turner RS, Ostrem JL, Davis VR, Starr PA. Neuronal responses to passive movement in the globus pallidus internus in primary dystonia. J Neurophysiol 2007;98:3696-3707.
11. Alam M, Schwabe K, Lütjens G, et al. Comparative characterization of single cell activity in the globus pallidus internus of patients with dystonia or Tourette syndrome. J Neural Transm 2015;122:687-699.
12. Miocinovic S, Hemptinne C de, Qasim S, Ostrem JL, Starr PA. Patterns of cortical synchronization in isolated dystonia compared with Parkinson disease. JAMA Neurol 2015;72:1244-1251.
13. Chung M, Huh R. Different clinical course of pallidal deep brain stimulation for phasic- and tonic-type cervical dystonia. Acta Neurochir 2016;158:171-180.
14. McClelland VM, Valentin A, Rey HG, et al. Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia. J Neurol Neurosurg Psychiatry 2016; doi.10.1136/jnnp-2015-311803 [Epub ahead of print].
15. FitzGerald JJ, Rosendal F, Pennington N de, et al. Long-term outcome of deep brain stimulation in generalised dystonia: a series of 60 cases. J Neurol Neurosurg Psychiatry 2014;85:1371-1376.
16. Groen JL, Ritz K, Contarino MF, et al. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord 2010;25:2420-2427.
17. Panov F, Tagliati M, Ozelius LJ, et al. Pallidal deep brain stimulation for DYT6 dystonia. J Neurol Neurosurg Psychiatry 2012;83:182-187.
18. Krause P, Brüggemann N, Völzmann S, et al. Long-term effect on dystonia after pallidal deep brain stimulation (DBS) in three members of a family with a THAP1 mutation. J Neurol 2015;262:2739-2744.
19. Pouclet-Courtemanche H, Rouaud T, Thobois S, et al. Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia. Neurology 2016;86:651-659.
20. Mikati MA, Yehya A, Darwish H, Karam P, Comair Y. Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol 2009;13:61-64.
21. Tanrıkulu B, Özen A, Günal DI, T et al. Deep brain stimulation as treatment for dystonic storm in pantothenate kinase-associated neurodegeneration syndrome: case report of a patient with homozygous C.628 2 T > G mutation of the PANK2 gene. Acta Neurochir 2015;157:1513-1516.
22. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
23. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012;79:55-65.
24. Odekerken VJJ, Boel JA, Geurtsen GJ, et al. Neuropsychological outcome after deep brain stimulation for Parkinson disease. Neurology 2015;84:1355-1361.
25. Fasano A, Lozano AM. Deep brain stimulation for movement disorders: 2015 and beyond. Curr Opin Neurol 2015;28:423-436.
26. Ponce FA, Asaad WF, Foote KD, et al. Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial. J Neurosurg 2015:1-10.
27. Ferraye MU, Debû B, Fraix, V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133:205-214.
28. Moro E, Hamani C, Poon Y-Y, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010;133:215-224.
29. Welter M-L, Demain A, Ewenczyk C, et al. PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. J Neurol 2015;262:1515-1525.
30. Collomb-Clerc A, Welter M-L. Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: A systematic neurophysiological review. Neurophysiol Clin 2015;45:371-388.
31. Fuentes R, Petersson P, Siesser WB, Caron MG, Nicolelis MAL. Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science 2009;323:1578-1582.
32. Fuentes R, Petersson P, Nicolelis MAL. Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach. Eur J Neurosci 2010;32:1100-1108.
33. Agari T, Date I. Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson's disease. Neurol Med Chir 2012;52:470-474.
34. Hassan S, Amer S, Alwaki A, Elborno A. A patient with Parkinson's disease benefits from spinal cord stimulation. J Clin Neurosci 2013;20:1155-1156.
35. Thiriez C, Gurruchaga J-M, Goujon C, Fénelon G, Palfi S. Spinal stimulation for movement disorders. Neurotherapeutics 2014;11:543-552.
36. Andrade EM de, Ghilardi MG, Cury RG, et al. Spinal cord stimulation for Parkinson's disease: a systematic review. Neurosurg Rev 2016;39:27-35.
37. Starr P a., Christine CW, Theodosopoulos P V, et al. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002;97:370-387.
38. Ostrem JL, Ziman N, Galifianakis NB, et al. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. J Neurosurg 2015:1-9.
39. Mirzadeh Z, Chapple K, Lambert M, et al. Parkinson's disease outcomes after intraoperative CT-guided “asleep” deep brain stimulation in the globus pallidus internus. J Neurosurg 2015:1-6.
40. Phillips MD, Baker KB, Lowe MJ, et al. Parkinson disease: pattern of functional MR imaging activation during deep brain stimulation of subthalamic nucleus--initial experience. Radiology 2006;239:209-216.
41. Kahan J, Papadaki A, White M, et al. The safety of using body-transmit MRI in patients with implanted deep brain stimulation devices. PLoS One 2015;10:e0129077.
42. Lipsman N, Schwartz ML, Huang Y, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 2013;12:462-468.
43. Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640-648.
44. Schlesinger I, Eran A, Sinai A, et al. MRI Guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson's disease. Parkinsons Dis 2015;2015:219149.
45. Abosch A, Yacoub E, Ugurbil K, Harel N. An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla. Neurosurgery 2010;67:1745-1756.
46. Cho Z-H, Min H-K, Oh S-H, et al. Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging. J Neurosurg 2010;113:639-647.
47. Groppa S, Herzog J, Falk D, Riedel C, Deuschl G, Volkmann J. Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor. Brain 2014;137:109-121.
48. Gillies MJ, Joint C, Forrow B, Fletcher C, Green AL, Aziz TZ. Rechargeable vs. nonrechargeable internal pulse generators in the management of dystonia. Neuromodulation 2013;16:226-229.
49. Timmermann L, Schüpbach M, Hertel F, et al. A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey. Eur Neurol 2013;69:193-199.
50. Waln O, Jimenez-Shahed J. Rechargeable deep brain stimulation implantable pulse generators in movement disorders: patient satisfaction and conversion parameters. Neuromodulation 2014;17:425-430.
51. Rizzi M, Messina G, Penner F, D'Ammando A, Muratorio F, Franzini A. Internal pulse generators in deep brain stimulation: rechargeable or not? World Neurosurg 2015;84:1020-1029.
52. Timmermann L, Jain R, Chen L, et al. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. Lancet Neurol 2015;14:693-701.
53. Contarino MF, Brinke TRT, Mosch A, et al. How many patients would benefit from steering technology for deep brain stimulation? Brain Stimul 2016;9:144-145.
54. Pollo C, Kaelin-Lang A, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain 2014;137:2015-2026.
55. Butson CR, McIntyre CC. Current steering to control the volume of tissue activated during deep brain stimulation. Brain Stimul 2008;1:7-15.
56. Willsie AC, Dorval AD. Computational field shaping for deep brain stimulation with thousands of contacts in a novel electrode geometry. Neuromodulation 2015;18:542-550.
57. Rosin B, Slovik M, Mitelman R, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011;72:370-384.
58. Hemptinne C de, Swann NC, Ostrem JL, et al. Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci 2015;18:779-786.
59. Sun FT, Morrell MJ. The RNS System: responsive cortical stimulation for the treatment of refractory partial epilepsy. Expert Rev Med Devices 2014;11:563-572.
60. Priori A, Foffani G, Rossi L, Marceglia S. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations. Exp Neurol 2013;245:77-86.
61. Almeida L, Martinez-Ramirez D, Rossi PJ, Peng Z, Gunduz A, Okun MS. Chasing tics in the human brain: development of open, scheduled and closed loop responsive approaches to deep brain stimulation for tourette syndrome. J Clin Neurol 2015;11:122-131.
62. Beudel M, Brown P. Adaptive deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord 2016;22(Suppl 1):S123-S126.
63. Neumann W-J, Staub F, Horn A, et al. Deep brain recordings using an implanted pulse generator in Parkinson's disease. Neuromodulation 2016;19:20-24.
64. Buttery PC, Barker RA. Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? J Comp Neurol 2014;522:2802-2816.
65. Barker RA, Drouin-Ouellet J, Parmar M. Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol 2015;11:492-503.
66. Rowland NC, Starr PA, Larson PS, Ostrem JL, Marks WJ Jr, Lim DA. Combining cell transplants or gene therapy with deep brain stimulation for Parkinson's disease. Mov Disord 2015;30:190-195.
67. Rowland NC, Kalia SK, Kalia LV, Larson PS, Lim DA, Bankiewicz KS. Merging DBS with viral vector or stem cell implantation: “hybrid” stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease. Mol Ther Methods Clin Dev 2016;3:15051.